Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting 8-12-2025, 05:30

Evergreen and CIP team up to explore green shipping fuels 20-10-2023, 16:28

eXp Realty Launches in Ecuador, Onboards Country’s Top Real Estate Sales Team as Kléver Guanoluisa Torres Leads Latin America Growth Surge 16-05-2025, 23:00